
FDA’s Breakthrough Designation Now Includes Health Equity Provision
Though not expected to drastically change the program, new component gives device makers another way to strengthen their submissions
Though not expected to drastically change the program, new component gives device makers another way to strengthen their submissions
The ALZpath DX assay is less invasive than other diagnostic tests, and may give patients diagnosed with Alzheimer’s more time to plan
The FDA is adding International Organization for Standardization (ISO) guidelines to its “good manufacturing” requirements
UK-developed assay that uses a sponge appears to reduce the need for more invasive endoscopies.
Whether the MiniDraw™ device dredges up memories of Theranos’ failed tech remains to be seen.